ClinicalTrials.Veeva

Menu
C

Columbus Neuroscience LLC | Westerville, OH

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Tyrosine
Tolebrutinib
SAR442168
Ocrelizumab
Sodium Oligomannate
Ofatumumab
GV-971
Teriflunomide
Remibrutinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 9 total trials

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis (OLERO)

This is a Phase IIIb, single-arm, multicenter, OLE study. Participants receiving ocrelizumab as an investigational medicinal product (IMP) in a Roche...

Active, not recruiting
Multiple Sclerosis
Drug: Ocrelizumab

This study will evaluate the efficacy and safety of ocrelizumab ( Ocrevus®) compared with placebo in participants with primary progressive multiple s...

Active, not recruiting
Multiple Sclerosis, Primary Progressive
Drug: Ocrelizumab
Drug: Placebo

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)

Enrolling
Relapsing Multiple Sclerosis
Drug: Teriflunomide
Drug: Remibrutinib

The purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have particip...

Active, not recruiting
Relapsing Multiple Sclerosis
Biological: 23-valent pneumococcal polysaccharide vaccine (23-PPV)
Biological: Tetanus toxoid (TT) containing vaccine (Td, Tdap)

Trial sponsors

Novartis logo
Roche logo
Sanofi logo
G

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems